At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 610 enrolled
Drug / intervention
Tamsulosin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
In Brief
A Phase 4 clinical trial evaluating Tamsulosin and Placebo for Post-operative Urinary Retention. Completed, enrolled 610 participants across 1 site.
Detailed Summary
Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-operative Urinary Retention
CountriesUnited States
CollaboratorsMaineHealth
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedSep 2016
Primary CompletionJan 2020
Study CompletionNov 2020
TodayJul 2026
First PostedSep 29, 2016
Enrollment StartMar 1, 2016
Primary CompletionJan 1, 2020
Study CompletionNov 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 9.8 years ago
Interventions
Tamsulosindrug
Active drug
Placebodrug
Lactose-filled capsules identical to active drug